These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1385551)

  • 1. The antiviral effects of the interferons and their inhibition.
    Kerr IM; Stark GR
    J Interferon Res; 1992 Aug; 12(4):237-40. PubMed ID: 1385551
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
    Routes JM
    J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective response to interferons in cells transfected with the hepatitis B virus genome.
    Onji M; Lever AM; Saito I; Thomas HC
    Hepatology; 1989 Jan; 9(1):92-6. PubMed ID: 2461895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
    Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
    Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis.
    Kato A; Ohnishi Y; Hishiyama M; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2002 Jul; 76(14):7114-24. PubMed ID: 12072511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins with transcription regulatory properties encoded by human adenoviruses.
    Akusjärvi G
    Trends Microbiol; 1993 Aug; 1(5):163-70. PubMed ID: 8143133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of inhibitors that destroy cytoskeleton structures on the antiviral and antiproliferative activity of interferons].
    Solov'eva MF; Krispin TI; Shloma DV; Kalmakhelidze KA; Balandin IG
    Vopr Virusol; 1988; 33(3):309-14. PubMed ID: 2459850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus.
    Isorce N; Testoni B; Locatelli M; Fresquet J; Rivoire M; Luangsay S; Zoulim F; Durantel D
    Antiviral Res; 2016 Jun; 130():36-45. PubMed ID: 26971407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The present state of research in direct antiviral mechanism of interferon on hepatitis B virus].
    Liu F; Tang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1358-62, 1371. PubMed ID: 20095503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis B virus replication by interferon requires proteasome activity.
    Robek MD; Wieland SF; Chisari FV
    J Virol; 2002 Apr; 76(7):3570-4. PubMed ID: 11884582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3.
    Juang YT; Lowther W; Kellum M; Au WC; Lin R; Hiscott J; Pitha PM
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9837-42. PubMed ID: 9707562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase.
    Haig DM; McInnes CJ; Thomson J; Wood A; Bunyan K; Mercer A
    Immunology; 1998 Mar; 93(3):335-40. PubMed ID: 9640243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.
    Gordien E; Rosmorduc O; Peltekian C; Garreau F; Bréchot C; Kremsdorf D
    J Virol; 2001 Mar; 75(6):2684-91. PubMed ID: 11222692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I and type II interferons: differential antiviral actions in transformed cells.
    Bourgeade MF; Chany C; Merigan TC
    J Gen Virol; 1980 Feb; 46(2):449-54. PubMed ID: 6155431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of a palindromic DNA sequence by ESF-1, a factor stimulating transcription of the adenovirus type 12 E1A gene.
    Shibata-Sakurai H; Masamune Y; Nakanishi Y
    Biol Pharm Bull; 1993 Jan; 16(1):87-9. PubMed ID: 8369759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation and inhibition of interferon action: antiviral and antitumor studies.
    Fleishmann WR
    Med Pediatr Oncol; 1981; 9(1):89-92. PubMed ID: 6162087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-interferon activity of extracts of cells transformed by SV40 virus].
    Brodeur B; Légaré C; Brailovsky CA
    Can J Microbiol; 1973 Jan; 19(1):7-14. PubMed ID: 4346586
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-suppressor genes: news about the interferon connection.
    Lengyel P
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5893-5. PubMed ID: 7687056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
    Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
    Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.